Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Kurbacher · SciRah

Researcher profile · Semantic Scholar

C. Kurbacher

Share profile

C. Kurbacher — researcher profile on SciRah

h-index: 30
Works: 173
Citations: 2,978

Most-cited papers

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.
V. Moebus, C. Jackisch, H. Lueck, A. du Bois +13 more
2010Journal of Clinical Oncology197 citations Open access
Semantic Scholar
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
A. Hartkopf, J. Huober, B. Volz, N. Nabieva +29 more
2018Breast63 citations Open access
Semantic Scholar
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.
A. Hein, A. Hartkopf, J. Emons, M. Lux +26 more
2021European Journal of Cancer56 citations
Semantic Scholar
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V. Möbus, C. Jackisch, H. Luck, A. du Bois +12 more
2018Annals of Oncology48 citations Open access
Semantic Scholar
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
M. Lux, N. Nabieva, A. Hartkopf, J. Huober +27 more
2018Cancers48 citations Open access
Semantic Scholar
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial
H. Tesch, O. Stoetzer, T. Decker, C. Kurbacher +13 more
2018International Journal of Cancer47 citations Open access
Semantic Scholar
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial
V. Moebus, C. Jackisch, A. Schneeweiss, J. Huober +10 more
2013Journal of the National Cancer Institute38 citations Open access
Semantic Scholar
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts
C. Thomssen, D. Lüftner, M. Untch, R. Haidinger +20 more
2020Breast Care35 citations Open access
Semantic Scholar
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
T. Engler, P. Fasching, D. Lüftner, A. Hartkopf +29 more
2022Geburtshilfe und Frauenheilkunde33 citations Open access
Semantic Scholar
A Head to Head Comparison Between SurgiMend® - Fetal Bovine Acellular Dermal Matrix and Tutomesh® - A Bovine Pericardium Collagen Membrane in Breast Reconstruction in 45 Cases.
C. Eichler, Jeria Efremova, K. Brunnert, C. Kurbacher +3 more
2017In Vivo25 citations Open access
Semantic Scholar
Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.
C. Kurbacher, O. Horn, J. Kurbacher, S. Herz +3 more
2015The Oncologist23 citations Open access
Semantic Scholar
LBA9BREAST CANCER TREATMENT WITH EVEROLIMUS AND EXEMESTANE FOR ER+ WOMEN - RESULTS OF THE 2ND INTERIM ANALYSIS OF THE NON-INTERVENTIONAL TRIAL BRAWO
P. Fasching, T. Decker, A. Schneeweiss, C. Uleer +16 more
201423 citations Open access
Semantic Scholar
Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response
P. Kern, A. Kalisch, H. Kolberg, R. Kimmig +5 more
2014Chemotherapy20 citations Open access
Semantic Scholar
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival
P. Kern, A. Kalisch, G. von Minckwitz, Carolin Pütter +5 more
2016Journal of chemotherapy18 citations
Semantic Scholar
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
C. Kurbacher, T. Fietz, I. Diel, Matthias Egert +17 more
2015Oncology Research and Treatment16 citations Open access
Semantic Scholar
31P and 1H Nuclear Magnetic Resonance Spectroscopy of Blood Plasma in Female Patients with Preeclampsia
S. Schott, J. Hahn, C. Kurbacher, D. Moka
2012International Journal of Biomedical Science15 citations Open access
Semantic Scholar
Isolation and culture of ovarian cancer cells and cell lines.
C. Kurbacher, C. Korn, S. Dexel, U. Schween +3 more
2011Methods in molecular biology13 citations
Semantic Scholar
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving Anthracycline-Cyclophosphamide-Based Chemotherapy
J. Schilling, C. Kurbacher, C. Hanusch, S. Busch +5 more
2021Breast Care12 citations Open access
Semantic Scholar
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
V. Müller, A. Hein, A. Hartkopf, P. Fasching +25 more
2022European Journal of Cancer11 citations Open access
Semantic Scholar
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
L. Michel, A. Hartkopf, P. Fasching, H. Kolberg +26 more
2020Cancers11 citations Open access
Semantic Scholar
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR
T. Fietz, Andreas Lück, H. Schulz, J. Harde +7 more
2019Current Medical Research and Opinion11 citations
Semantic Scholar
Abstract P3-11-07: Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry
J. Huober, P. Fasching, F. Taran, B. Volz +27 more
20187 citations
Semantic Scholar
Abstract P5-21-09: Overall survival of metastatic breast cancer patients – data from the PRAEGNANT breast cancer registry
F. Taran, P. Fasching, B. Volz, J. Huober +27 more
20187 citations
Semantic Scholar
Panitumumab in platinum-sensitive epithelial ovarian cancer patients with KRAS wild-type: The PROVE-study, a phase II randomized multicenter study of the North-Eastern German Society of Gynaecologic Oncology.
R. Chekerov, P. Klare, P. Krabisch, J. Potenberg +7 more
20177 citations
Semantic Scholar
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
E. Laakmann, J. Emons, F. Taran, W. Janni +27 more
2020Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Abstract P5-19-06: 4EVER - Final efficacy analysis of the phase IIIb, multi-center, open label study for postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer (BC) treated with everolimus (EVE) in combination with exemestane (EXE)
H. Tesch, O. Stoetzer, T. Decker, C. Kurbacher +14 more
20156 citations
Semantic Scholar
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
H. Huebner, C. Kurbacher, G. Kuesters, A. Hartkopf +22 more
2020BMC Cancer5 citations Open access
Semantic Scholar
Abstract P6-17-22: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167)
A. Schneeweiss, M. Lux, A. Hartkopf, B. Volz +27 more
2019Poster Session Abstracts5 citations
Semantic Scholar
The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial
P. Hadji, O. Stoetzer, T. Decker, C. Kurbacher +13 more
2018Journal of Bone Oncology5 citations Open access
Semantic Scholar
Abstract P5-19-12: Subgroup analysis on efficacy in the routine treatment - Results of the 2nd interim analysis of BRAWO, the non-interventional trial "Breast Cancer Treatment with Everolimus and Exemestane for HR+ Women"
C. Jackisch, E. Grischke, A. Schneeweiss, T. Decker +16 more
20155 citations
Semantic Scholar
Intraoperative central nipple biopsy in nipple‐sparing mastectomy— A retrospective analysis of 211 patients
C. Eichler, S. Stephan, F. Thangarajah, J. Puppe +4 more
2021The Breast Journal4 citations Open access
Semantic Scholar
Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer
T. Decker, U. Söling, A. Hahn, C. Maintz +10 more
2020BMC Cancer4 citations Open access
Semantic Scholar
Return of individual genomic research results within the PRAEGNANT multicenter registry study
H. Huebner, M. Ruebner, C. Kurbacher, P. Hadji +24 more
2022Breast Cancer Research and Treatment3 citations Open access
Semantic Scholar
Pathologic response rate (pCR) and near-pathologic response rate (near-pCR) with docetaxel-carboplatin (TCarb) in early triple-negative breast cancer.
P. Kern, H. Kolberg, Anne Kalisch, C. Liedtke +3 more
2011Journal of Clinical Oncology3 citations
Semantic Scholar
Abstract PS10-31: Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results
M. Reinisch, A. Nusch, T. Decker, A. Hartkopf +15 more
20212 citations
Semantic Scholar
ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019
M. Untch, R. Würstlein, D. Lüftner, R. Haidinger +19 more
2020Geburtshilfe und Frauenheilkunde2 citations Open access
Semantic Scholar
Abstract P6-11-14: Safety and effectiveness of sensor-controlled scalp cooling to prevent alopecia in primary breast cancer patients receiving neoadjuvant or adjuvant epirubicin, taxanes, or both
C. Kurbacher, S. Herz, G. Kolberg, Nele Kettelhoit +4 more
20182 citations
Semantic Scholar
Sensor-controlled scalp cooling for chemotherapy-induced alopecia: Safety and effectiveness in primary breast cancer patients exposed to anthracyclines and/or taxanes in the neoadjuvant or adjuvant setting.
C. Kurbacher, S. Herz, A. T. Kurbacher, G. Kolberg +2 more
20182 citations
Semantic Scholar
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with breast cancer: results from an interim analysis of the non-interventional study NADIR
C. Kurbacher, T. Fietz, T. Trarbach, C. Salat +3 more
20162 citations Open access
Semantic Scholar
Results of the CARMA study to investigate catumaxomab therapy for ascites related to peritoneal carcinomatosis in clinical practice.
C. Kurbacher, J. Sehouli, M. Welslau, G. Tempelhoff +6 more
20132 citations
Semantic Scholar
Updated results of neoadjuvant chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 in triple-negative breast cancer (TNBC).
P. Kern, H. Kolberg, A. Kalisch, R. Kimmig +3 more
2013Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract P1-15-02: Febrile neutropenia (FN) risk assessment and granulocyte colony-stimulating factor (G-CSF) guideline adherence in patients with breast cancer – results from a German prospective multicentre observational study (PROTECT)
C. Steffens, H. Eschenburg, C. Kurbacher, T. Goehler +4 more
20122 citations
Semantic Scholar
Intense dose-dense (idd) sequential chemotherapy with epirubicin (E), paclitaxel (T), and cyclophosphamide (C) (ETC) compared with conventionally scheduled chemotherapy in high-risk breast cancer patients (> 3+LN): Eight-year follow-up analysis.
V. Moebus, C. Thomssen, H. Lueck, W. Kuhn +10 more
2011Journal of Clinical Oncology2 citations
Semantic Scholar
247P Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study
T. Decker, P. Fasching, A. Nusch, A. Hartkopf +16 more
2021Annals of Oncology1 citations Open access
Semantic Scholar
Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
E. Laakmann, J. Emons, F. Taran, W. Janni +27 more
2020Geburtshilfe und Frauenheilkunde1 citations Open access
Semantic Scholar
The Need for Psycho-Oncological Support in Breast Cancer Patients – A Longitudinal Study in an Outpatient- Setting
C. Kurbacher, R. Reichelt, R. Schnell
2019Psychology and Mental Health Care1 citations Open access
Semantic Scholar
Abstract P1-11-10: Efficacy of NEPA as antiemetic prophylaxis in breast cancer patients receiving highly or moderately emetogenic chemotherapy – Interim results of a German prospective, non-interventional study
J. Schilling, C. Hielscher, C. Hanusch, C. Kurbacher +2 more
2019Poster Session Abstracts1 citations
Semantic Scholar
RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the first interim analysis.
P. Fasching, A. Nusch, B. Heinrich, S. Brucker +14 more
20181 citations
Semantic Scholar
Use of primary and secondary pegfilgrastim prophylaxis for reducing incidence of neutropenia: Findings from a large study in German clinical practice (PROTECT).
C. Kurbacher, M. Schmidt, M. Geberth, B. Otremba +2 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in women treated for either breast or female genital tract cancer: A German experience using the Paxman system.
C. Kurbacher, S. Herz, G. Kolberg, N. Kettelhoit +3 more
20161 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Schneeweiss×23
Invite
A. Schneeweiss — researcher profile on SciRah
H. Tesch×21
Invite
H. Tesch — researcher profile on SciRah
P. Fasching×20
Invite
P. Fasching — researcher profile on SciRah
D. Lüftner×19
Invite
D. Lüftner — researcher profile on SciRah

×18

Invite

M. Untch — researcher profile on SciRah

Invite

W. Janni — researcher profile on SciRah

Invite

T. Fehm — researcher profile on SciRah

Invite

F. Taran — researcher profile on SciRah

Invite

P. Hadji — researcher profile on SciRah

Invite

J. Ettl — researcher profile on SciRah

Invite

M. Lux — researcher profile on SciRah

P. Wimberger×14

Invite

P. Wimberger — researcher profile on SciRah